Overview

Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility

Status:
Completed
Trial end date:
2000-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether prucalopride is safe and effective in the treatment of constipation in elderly subjects living in a nursing facility. Hypothesis: Prucalopride up to a dose of 4 mg once daily is safe and well tolerated in in elderly subjects living in a nursing facility.
Phase:
Phase 2
Details
Lead Sponsor:
Movetis
Treatments:
Prucalopride